New hope for tough ovarian cancers: targeted drug CUSP06 enters human testing
NCT ID NCT06234423
First seen Nov 01, 2025 · Last updated May 09, 2026 · Updated 29 times
Summary
This study tests a new drug called CUSP06 for people with ovarian cancer or other solid tumors that have stopped responding to standard treatments. The drug works like a guided missile, targeting a protein on cancer cells to deliver a powerful toxin directly. The main goals are to find the safest dose and see if it can shrink tumors. About 263 adults will take part in this early-phase trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dana Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 02115, United States
Contact
-
Florida Cancer Specialists
RECRUITINGSarasota, Florida, 34232, United States
Contact
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact
-
Mater Cancer Care Centre
RECRUITINGSouth Brisbane, Queensland, 4101, Australia
Contact
-
Memorial Sloan Kettering Cancer Center
RECRUITINGNew York, New York, 10021, United States
Contact
-
Mount Sinai Medical Center
RECRUITINGMiami Beach, Florida, 33140, United States
Contact
-
NEXT Oncology
RECRUITINGHouston, Texas, 77054, United States
Contact
-
NEXT Oncology
RECRUITINGFairfax, Virginia, 22031, United States
Contact
-
NYU Cancer Institute Clinical Cancer Center
RECRUITINGNew York, New York, 10016, United States
Contact
-
SCRI Oncology Partners
RECRUITINGNashville, Tennessee, 37203, United States
Contact
-
START Midwest
RECRUITINGGrand Rapids, Michigan, 49546, United States
Contact
-
START San Antonio
RECRUITINGSan Antonio, Texas, 78229, United States
Contact
-
Sarah Cannon Research Institute at HealthONE
RECRUITINGDenver, Colorado, 80218, United States
Contact
-
Stephenson Cancer Center
RECRUITINGOklahoma City, Oklahoma, 73104, United States
Contact
-
Yale University
RECRUITINGNew Haven, Connecticut, 06520, United States
Contact
Conditions
Explore the condition pages connected to this study.